Skip to main content
. 2010 Oct 26;341:c5688. doi: 10.1136/bmj.c5688

Table 9.

 Results of individual studies with return to work and sport as outcome measure classified by duration of follow-up

Outcome Conventional treatment Supervised treatment Effect size or relative risk* (95% CI)
Short term
Brooks23
No of days off work 5.1/7.5/14.0† 6.0 NA
Hultman30
Mean (SD) No of days off work 6.1 (7.4) 4.6 (6.1) 0.22‡ (−0.34 to 0.77)
Karlsson21
Mean (SD) No of days of sick 10.2 (6.8) 5.6 (4.2) 0.82‡ (0.37 to 1.27)§
Nilsson25
Mean No of days of sick leave 12.7 11.5 NA
Reinhardt27
Mean (SD) days before return to work 8.7 (3.1) 5.7 (3.1) 0.96† (0.49 to 1.43)§
Intermediate
Oostendorp26
No (%) who had returned to work:
 At 6 weeks 10 (85) 10 (86) 1.00 (0.70 to 1.43)
 At 12 weeks 11 (88) 11 (91) 1.00 (0.79 to 1.27)
Long term
Oostendorp26
No (%) who returned to work at 24 weeks 11 (91) 11 (94) 1.00 (0.79 to 1.27)
Short term
Karlsson21
Mean (SD) No of days before return to sports activity 19.2 (9.5) 9.6 (4.8) 1.29† (0.82 to 1.76)§
Reinhardt27
Days before return to sports 13.8 11.7 NA
Intermediate
Oostendorp26
No (%) who returned to sports training:
 At 6 weeks 7 (62) 4 (30) 0.57 (0.22 to 1.45)
 At 12 weeks 11 (88) 5 (43) 0.45 (0.23 to 0.91)§
Long term
Oostendorp26
No (%) who returned to sports training at 24 weeks 11 (96) 9 (74) 0.82 (0.57 to 1.18)

*Effect size >0 indicates beneficial effects of supervised treatment; relative risk <1.0 indicates beneficial effects of supervised treatment.

†In conventional treatment groups: no treatment, no support, or only minimal bandaging/double Tubigrip worn during day/complete immobilisation of ankle in below knee cast, weight bearing encouraged as soon as possible (see table 2).

‡Effect size.

§P<0.05.